Rita Secola

498 total citations
22 papers, 336 citations indexed

About

Rita Secola is a scholar working on Pediatrics, Perinatology and Child Health, Neurology and Hematology. According to data from OpenAlex, Rita Secola has authored 22 papers receiving a total of 336 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pediatrics, Perinatology and Child Health, 6 papers in Neurology and 6 papers in Hematology. Recurrent topics in Rita Secola's work include Childhood Cancer Survivors' Quality of Life (8 papers), Neuroblastoma Research and Treatments (6 papers) and Neutropenia and Cancer Infections (5 papers). Rita Secola is often cited by papers focused on Childhood Cancer Survivors' Quality of Life (8 papers), Neuroblastoma Research and Treatments (6 papers) and Neutropenia and Cancer Infections (5 papers). Rita Secola collaborates with scholars based in United States, Canada and Brazil. Rita Secola's co-authors include Gregory H. Reaman, Mitchell S. Cairo, Anne Angiolillo, Eufémia Jacob, Alice L. Yu, Peter C. Adamson, Ashish M. Ingle, Michelle Darezzo Rodrigues Nunes, Kathleen Adlard and Lucila Castanheira Nascimento and has published in prestigious journals such as PLoS ONE, Cancer and British Journal of Haematology.

In The Last Decade

Rita Secola

20 papers receiving 325 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rita Secola United States 11 107 98 91 87 37 22 336
Ida Hed Myrberg Sweden 14 115 1.1× 155 1.6× 135 1.5× 74 0.9× 19 0.5× 35 454
Maureen Haugen United States 10 89 0.8× 55 0.6× 94 1.0× 33 0.4× 33 0.9× 14 309
Jeffrey D. Hord United States 15 201 1.9× 95 1.0× 198 2.2× 83 1.0× 7 0.2× 34 568
M.-D. Tabone France 9 182 1.7× 90 0.9× 36 0.4× 67 0.8× 11 0.3× 25 457
Zarina Abdul Latiff Malaysia 11 107 1.0× 46 0.5× 76 0.8× 69 0.8× 14 0.4× 53 349
Stacy Cooper United States 12 262 2.4× 264 2.7× 87 1.0× 118 1.4× 50 1.4× 34 516
S. Brunet Canada 11 194 1.8× 297 3.0× 162 1.8× 53 0.6× 27 0.7× 15 616
Micah Skeens United States 13 148 1.4× 81 0.8× 121 1.3× 81 0.9× 5 0.1× 57 476
F Saunders Canada 8 117 1.1× 77 0.8× 59 0.6× 71 0.8× 46 1.2× 8 328
Pinki Prasad United States 12 408 3.8× 267 2.7× 29 0.3× 117 1.3× 19 0.5× 24 639

Countries citing papers authored by Rita Secola

Since Specialization
Citations

This map shows the geographic impact of Rita Secola's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rita Secola with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rita Secola more than expected).

Fields of papers citing papers by Rita Secola

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rita Secola. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rita Secola. The network helps show where Rita Secola may publish in the future.

Co-authorship network of co-authors of Rita Secola

This figure shows the co-authorship network connecting the top 25 collaborators of Rita Secola. A scholar is included among the top collaborators of Rita Secola based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rita Secola. Rita Secola is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Secola, Rita, et al.. (2022). Multidisciplinary Clinical Care in the Management of Patients Receiving Anti-GD2 Immunotherapy for High-Risk Neuroblastoma. Pediatric Drugs. 25(1). 13–25. 8 indexed citations
2.
3.
Nunes, Michelle Darezzo Rodrigues, Fernanda Machado Silva‐Rodrigues, Rita Secola, et al.. (2019). Frequency, Severity, and Distress Associated With Physical and Psychosocial Symptoms at Home in Children and Adolescents With Cancer. Journal of Pediatric Health Care. 33(4). 404–414. 26 indexed citations
4.
Adlard, Kathleen, et al.. (2019). Quality of Life and Pain Experienced by Children and Adolescents With Cancer at Home Following Discharge From the Hospital. Journal of Pediatric Hematology/Oncology. 42(1). 46–52. 20 indexed citations
5.
Secola, Rita, et al.. (2019). Back to Basics: CLABSI Reduction Through Implementation of an Oral Care and Hygiene Bundle. Journal of Pediatric Oncology Nursing. 36(5). 321–326. 8 indexed citations
6.
Secola, Rita, et al.. (2017). The Role of Nursing Professionals in the Management of Patients With High-Risk Neuroblastoma Receiving Dinutuximab Therapy. Journal of Pediatric Oncology Nursing. 34(3). 160–172. 2 indexed citations
7.
Nunes, Michelle Darezzo Rodrigues, Eufémia Jacob, Kathleen Adlard, Rita Secola, & Lucila Castanheira Nascimento. (2015). Fatigue and Sleep Experiences at Home in Children and Adolescents With Cancer. Oncology nursing forum. 42(5). 498–506. 28 indexed citations
8.
Secola, Rita, Mary Ann Lewis, Nancy A. Pike, Jack Needleman, & Lynn V. Doering. (2012). Feasibility of the Use of a Reliable and Valid Central Venous Catheter Blood Draw Bundle Checklist. Journal of Nursing Care Quality. 27(3). 218–225. 3 indexed citations
9.
Secola, Rita, Mary Ann Lewis, Nancy A. Pike, Jack Needleman, & Lynn V. Doering. (2012). “Targeting to Zero” in Pediatric Oncology. Journal of Pediatric Oncology Nursing. 29(1). 14–27. 10 indexed citations
10.
Secola, Rita, Colleen Azen, Mary Ann Lewis, et al.. (2012). A Crossover Randomized Prospective Pilot Study Evaluating a Central Venous Catheter Team in Reducing Catheter-Related Bloodstream Infections in Pediatric Oncology Patients. Journal of Pediatric Oncology Nursing. 29(6). 307–315. 5 indexed citations
11.
Morgan, Helen, et al.. (2012). A Self-Care Retreat for Pediatric Hematology Oncology Nurses. Journal of Pediatric Oncology Nursing. 30(1). 18–23. 25 indexed citations
12.
Shah, Ami J., et al.. (2010). The Utility of Routine Surveillance Blood Cultures in Asymptomatic Hematopoietic Stem Cell Transplant Patients. Journal of Pediatric Hematology/Oncology. 32(4). 327–331. 6 indexed citations
13.
Secola, Rita, et al.. (2010). Perinatal Germ Cell Tumors. Advances in Neonatal Care. 10(3). 133–139. 5 indexed citations
14.
Angiolillo, Anne, Alice L. Yu, Gregory H. Reaman, et al.. (2009). A phase II study of Campath‐1H in children with relapsed or refractory acute lymphoblastic leukemia: A Children's Oncology Group report. Pediatric Blood & Cancer. 53(6). 978–983. 68 indexed citations
15.
16.
Bracho, Francisco, Mark Krailo, Violet Shen, et al.. (2001). A phase I clinical, pharmacological, and biological trial of interleukin 6 plus granulocyte-colony stimulating factor after ifosfamide, carboplatin, and etoposide in children with recurrent/refractory solid tumors: enhanced hematological responses but a high incidence of grade III/IV constitutional toxicities.. PubMed. 7(1). 58–67. 13 indexed citations
17.
Cairo, Mitchell S., Mark Krailo, Joel Weinthal, et al.. (1998). A Phase I study of granulocyte-macrophage-colony stimulating factor/interleukin-3 fusion protein (PIXY321) following ifosfamide, carboplatin, and etoposide therapy for children with recurrent or refractory solid tumors: a report of the Children's Cancer Group.. PubMed. 83(7). 1449–60. 10 indexed citations
18.
19.
Secola, Rita. (1997). Pediatric blood cell transplantation. Seminars in Oncology Nursing. 13(3). 184–193.
20.
Rosenthal, Joseph, et al.. (1996). Phase II trial of heparin prophylaxis for veno-occlusive disease of the liver in children undergoing bone marrow transplantation.. PubMed. 18(1). 185–91. 46 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ida Hed Myrberg Breakdown of academic impact, for papers by Maureen Haugen Breakdown of academic impact, for papers by Jeffrey D. Hord Breakdown of academic impact, for papers by M.-D. Tabone Breakdown of academic impact, for papers by Zarina Abdul Latiff Breakdown of academic impact, for papers by Stacy Cooper Breakdown of academic impact, for papers by S. Brunet Breakdown of academic impact, for papers by Micah Skeens Breakdown of academic impact, for papers by F Saunders Breakdown of academic impact, for papers by Pinki Prasad
Rankless by CCL
2026